ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1801

Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype

Richard Loeser1, Jorge Fernandez Davila1, Philip Coryell2, Susan Chubinskaya3 and Doug Phanstiel4, 1University of North Carolina, Chapel Hill, NC, 2University of North Carolina-Chapel Hill, Chapel Hill, NC, 3University of Texas Medical Branch, Galveston, TX, 4University of North Carolina at Chapel Hill, Chapel Hill, NC

Meeting: ACR Convergence 2025

Keywords: chemokines, chondrocyte, Fibroblasts, Synovial, Osteoarthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Protease cleavage of matrix proteins generates matrix fragments including fibronectin fragments (FN-f) found in OA cartilage and synovial fluid. Matrix fragments or “matrikines” activate signaling to increase production of OA mediators promoting a feed-forward loop of matrix destruction. Stimulation of chondrocytes with an Fn-f (FN7-10) that binds the α5β1 integrin has been shown to model the OA chondrocyte phenotype. Synovial fibroblasts contribute to OA by producing factors that promote synovitis and cartilage destruction. The purpose of this study was to determine if FN7-10 activates synovial fibroblasts to produce factors that promote monocyte migration, differentiation, and an OA chondrocyte phenotype.

Methods: OA synovial fibroblasts (SFs) were isolated from tissue obtained during knee replacement and chondrocytes from normal cartilage were from tissue donors. RNA and serum-free conditioned media were collected after 18 hours of stimulation of SFs with FN7-10 or PBS as control and used for RNAseq, cytokine/chemokine protein arrays for 80 proteins and Luminex assays designed to measure 18 OA mediators. To evaluate the effects of activated SFs on the OA microenvironment, a 4-hour FN7-10 stimulation was performed, followed by a transition to serum-free medium and overnight incubation. The conditioned media was harvested and assessed for its chemotactic effects on THP1 monocytes, and its impact on the expression of inflammatory mediators in THP1 monocytes and chondrocytes.

Results: SF RNAseq revealed 1487 differentially expressed (DE) genes (772 up and 715 down) in response to FN7-10 vs PBS control (DESeq2, adjusted p value < 0.05, absolute differences of log2 fold-change >1). Upregulated genes were enriched for KEGG pathways including TNF and IL-17 signaling, cytokine-cytokine receptor interaction, and NOD-like,Toll-like receptor, and NFκB signaling. There were 22 upregulated chemokine genes (Fig.1) many of which also exhibited increased protein levels (greater than 2-fold) as detected by cytokine/chemokine protein arrays and/or Luminex including IL-6, CXCL5, CCL5, MCP1-3, CXCL10, CXCL20, LIF, FGF-2, MMP-3, MMP-13 and TNFα. Conditioned media from SFs stimulated by FN7-10 induced monocyte migration, which was blocked by CCR2 and CXCR2 chemokine receptor inhibitors (Fig. 2), and induced macrophage differentiation. Chondrocytes incubated with SF FN7-10 conditioned media demonstrated significant increases in expression of OA mediators and a downregulation of aggrecan (ACAN) and COL2A1 (Table 1).

Conclusion: OA SFs produce proinflammatory cytokines, chemokines, and MMPs when exposed to a matrikine (FN7-10) produced by cartilage degradation. Chemokines released from activated SFs induce monocyte migration and promotion of a macrophage phenotype which could contribute to synovitis. SF factors also stimulated chondrocytes to produce key OA mediators, down regulate anabolic genes and increase expression of the OA biomarker CRTAC1. These findings demonstrate a mechanism for cross-talk between the synovium and cartilage mediated by cartilage matrix damage that could promote OA progression.

Supporting image 1

Supporting image 2Monocyte migration in response to synovial fibroblast conditioned media after FN7-10 stimulation. A). Serum-free conditioned media collected from OA synovial fibroblasts after treatment with FN7-10 or PBS as control was incubated with THP-1 cells in transwells. B). After 24hrs cells that had migrated out of the transwell to the well with conditioned media were counted (n=21 samples). C). THP-1 cells were pre-incubated with inhibitors to CCR2, CXCR2 or CXCR3 prior to placement in the transwells and treatment with the synovial fibroblast conditioned media. % migration was compared to cells without the receptor inhibitors set as 100%.

Supporting image 3RNA was isolated from chondrocytes treated for 24hrs with synovial fibroblast (SF) conditioned media (CM) obtained from SFs treated for 24hrs with FN7-10 or PBS control. n=5 chondrocyte donor samples treated with n=3 samples of SF conditioned media. p value = FN7-10 CM vs PBS CM on Delta Ct values, 2 tailed, paired t test


Disclosures: R. Loeser: None; J. Fernandez Davila: None; P. Coryell: None; S. Chubinskaya: None; D. Phanstiel: None.

To cite this abstract in AMA style:

Loeser R, Fernandez Davila J, Coryell P, Chubinskaya S, Phanstiel D. Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/matrikine-activation-of-synovial-fibroblasts-promotes-monocyte-migration-and-stimulates-an-oa-chondrocyte-phenotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/matrikine-activation-of-synovial-fibroblasts-promotes-monocyte-migration-and-stimulates-an-oa-chondrocyte-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology